1 Recommendations

1 Recommendations

1.1 Current evidence on the safety and efficacy of prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia is limited in quantity and quality. Therefore, this procedure should only be used in the context of research.

1.2 Further research, ideally in the form of randomised controlled trials, should report details of patient selection (including prostate size and the amount of median lobe enlargement), improvement in lower urinary tract symptoms in the short term and long term, re-intervention rates, and outcome measures of sexual function using established methods.

  • National Institute for Health and Care Excellence (NICE)